These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4111073)

  • 1. Levels of C'3 in the serum of patients with benign and malignant diseases of the prostate.
    Ablin RJ; Gonder MJ; Soanes WA
    Neoplasma; 1972; 19(1):61-5. PubMed ID: 4111073
    [No Abstract]   [Full Text] [Related]  

  • 2. [Identification of the C'3 component of human complement by electrophoresis on polyacrylamide gel].
    Lamy J; Vargues R; Weill J
    C R Seances Soc Biol Fil; 1967; 161(10):2021-5. PubMed ID: 4175793
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnostic value of the determination of C'3 (beta 1 C-beta 1 A) in immunological reactions].
    Barboni F; Poggi EA
    Boll Soc Ital Biol Sper; 1969 Aug; 45(16):1070-3. PubMed ID: 4986926
    [No Abstract]   [Full Text] [Related]  

  • 4. Levels of C'3 in the serum of patients with pemphigus.
    Ablin RJ
    J Invest Dermatol; 1971 Jun; 56(6):450-3. PubMed ID: 4103072
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunochemical quantitation of the third, fourth and fifth components of human complement: concentrations in the serum of healthy adults.
    Kohler PF; Müller-Eberhard HJ
    J Immunol; 1967 Dec; 99(6):1211-6. PubMed ID: 4168664
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum antibody levels of cytomegalovirus, herpes simplex type I and adenovirus in patients with benign or malignant prostatic neoplasms].
    Peker AF; Erkan I; Ozen HA; Ustaçelebi S; Ozdemir T
    Mikrobiyol Bul; 1986 Jul; 20(3):165-75. PubMed ID: 2436029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum levels of the C'3 component of complement (beta 1c-beta 1a globulin) in children with rheumatic disease. Study of a possible correlation between complement level and presence in the blood of anti-heart antibodies].
    Vaccaro R; Rossoni R; Alestra P
    Minerva Pediatr; 1971 Feb; 23(6):258-61. PubMed ID: 4102382
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathological basis for elevation of serum prostate specific antigen].
    Xia TL; Deng FM; Feng T
    Zhonghua Yi Xue Za Zhi; 1994 May; 74(5):306-8, 327. PubMed ID: 7525028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiepithelial antibodies in the serum of patients with benign and malignant diseases of the prostate.
    Ablin RJ
    Z Immunitatsforsch Exp Klin Immunol; 1973 Sep; 146(1):8-22. PubMed ID: 4143163
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum complement (C'3) levels in patients with autoimmune bullous skin diseases.
    Katz SI; Inderbitzin TM; Halprin KM
    Arch Dermatol; 1970 Oct; 102(4):368-70. PubMed ID: 4990488
    [No Abstract]   [Full Text] [Related]  

  • 11. Breakdown products of C 3 in human synovial fluids.
    Zvaifler NJ
    J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum levels of C'3 (beta-1-C-beta-1-A globulin) in malignant lymphogranuloma in childhood. (Determination with an immunological method)].
    Masi M; Vivarelli F
    Clin Pediatr (Bologna); 1971 Jun; 53(6):201-7. PubMed ID: 5003566
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative characteristics of the immunologic indicators in patients with prostatic adenoma and cancer].
    Savinov VA; Khalezov SP; Sviridova AM
    Urol Nefrol (Mosk); 1983; (2):17-20. PubMed ID: 6190286
    [No Abstract]   [Full Text] [Related]  

  • 14. [Behavior of C'3-concentration (beta-la-globulin) in inflammatory rheumatic diseases].
    Klein G
    Z Rheumaforsch; 1971; 30(3):104-8. PubMed ID: 4102837
    [No Abstract]   [Full Text] [Related]  

  • 15. The antibody response to Propionibacterium acnes is an independent predictor of serum prostate-specific antigen levels in biopsy-negative men.
    Shannon BA; Cohen RJ; Garrett KL
    BJU Int; 2008 Feb; 101(4):429-35. PubMed ID: 17850358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiprostasome antibody titres in benign and malignant prostate disease.
    Minelli A; Ronquist G; Carlsson L; Mearini E; Nilsson O; Larsson A
    Anticancer Res; 2005; 25(6C):4399-402. PubMed ID: 16334115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and determination of the complex between prostate-specific antigen and alpha 1-protease inhibitor in benign and malignant prostatic diseases.
    Zhang WM; Finne P; Leinonen J; Stenman UH
    Scand J Clin Lab Invest Suppl; 2000; 233():51-8. PubMed ID: 11317942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.
    Alper CA; Rosen FS
    J Clin Invest; 1967 Dec; 46(12):2021-34. PubMed ID: 6074005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Letter: Increase of beta 1c globulin (C'3) in cancer patients].
    Delpech B; Laumonier R; Martin C; Ropartz C
    Nouv Presse Med; 1975 Apr; 4(14):1045. PubMed ID: 805408
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum levels of C'3 (beta-1-C-beta-1-A globulin) in acute lymphoblastic leukemia in childhood. (Determination with an immunological method)].
    Masi M; Vivarelli F
    Clin Pediatr (Bologna); 1971 May; 53(5):175-82. PubMed ID: 5003565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.